Outcomes in patients with hyperglycemia affected by COVID-19: can we do more on glycemic control? C Sardu, N D’Onofrio, ML Balestrieri, M Barbieri, MR Rizzo, V Messina, ... Diabetes care 43 (7), 1408-1415, 2020 | 481 | 2020 |
SIRT1 and SIRT6 signaling pathways in cardiovascular disease protection N D'Onofrio, L Servillo, ML Balestrieri Antioxidants & redox signaling 28 (8), 711-732, 2018 | 317 | 2018 |
Bioavailability of encapsulated resveratrol into nanoemulsion-based delivery systems M Sessa, ML Balestrieri, G Ferrari, L Servillo, D Castaldo, N D’Onofrio, ... Food chemistry 147, 42-50, 2014 | 290 | 2014 |
Sirtuin 6 expression and inflammatory activity in diabetic atherosclerotic plaques: effects of incretin treatment ML Balestrieri, MR Rizzo, M Barbieri, P Paolisso, N D’Onofrio, A Giovane, ... Diabetes 64 (4), 1395-1406, 2015 | 196 | 2015 |
Effects of metformin therapy on coronary endothelial dysfunction in patients with prediabetes with stable angina and nonobstructive coronary artery stenosis: the CODYCE … C Sardu, P Paolisso, C Sacra, C Mauro, F Minicucci, M Portoghese, ... Diabetes Care 42 (10), 1946-1955, 2019 | 124 | 2019 |
Ergothioneine oxidation in the protection against high-glucose induced endothelial senescence: involvement of SIRT1 and SIRT6 N D’Onofrio, L Servillo, A Giovane, R Casale, M Vitiello, R Marfella, ... Free Radical Biology and Medicine 96, 211-222, 2016 | 120 | 2016 |
Sirtuins in vascular diseases: emerging roles and therapeutic potential N D'Onofrio, M Vitiello, R Casale, L Servillo, A Giovane, ML Balestrieri Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1852 (7 …, 2015 | 104 | 2015 |
Multiple pathways of SIRT6 at the crossroads in the control of longevity, cancer, and cardiovascular diseases M Vitiello, A Zullo, L Servillo, FP Mancini, A Borriello, A Giovane, ... Ageing research reviews 35, 301-311, 2017 | 97 | 2017 |
Does poor glycaemic control affect the immunogenicity of the COVID‐19 vaccination in patients with type 2 diabetes: the CAVEAT study R Marfella, N D'Onofrio, C Sardu, L Scisciola, P Maggi, N Coppola, ... Diabetes, Obesity and Metabolism 24 (1), 160-165, 2022 | 96 | 2022 |
Poor glycaemic control in type 2 diabetes patients reduces endothelial progenitor cell number by influencing SIRT1 signalling via platelet-activating factor receptor activation ML Balestrieri, L Servillo, A Esposito, N D’onofrio, A Giovane, R Casale, ... Diabetologia 56, 162-172, 2013 | 96 | 2013 |
Hyperglycaemia on admission to hospital and COVID-19 C Sardu, N D’Onofrio, ML Balestrieri, M Barbieri, MR Rizzo, V Messina, ... Diabetologia 63, 2486-2487, 2020 | 91 | 2020 |
An uncommon redox behavior sheds light on the cellular antioxidant properties of ergothioneine L Servillo, D Castaldo, R Casale, N D’Onofrio, A Giovane, D Cautela, ... Free Radical Biology and Medicine 79, 228-236, 2015 | 89 | 2015 |
Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte N D’onofrio, L Scisciola, C Sardu, MC Trotta, M De Feo, C Maiello, ... Cardiovascular diabetology 20 (1), 99, 2021 | 86 | 2021 |
Microplastics and nanoplastics in atheromas and cardiovascular events R Marfella, F Prattichizzo, C Sardu, G Fulgenzi, L Graciotti, T Spadoni, ... New England Journal of Medicine 390 (10), 900-910, 2024 | 83 | 2024 |
Pericoronary fat inflammation and Major Adverse Cardiac Events (MACE) in prediabetic patients with acute myocardial infarction: effects of metformin C Sardu, N D’Onofrio, M Torella, M Portoghese, F Loreni, S Mureddu, ... Cardiovascular Diabetology 18, 1-11, 2019 | 80 | 2019 |
Ergothioneine antioxidant function: from chemistry to cardiovascular therapeutic potential L Servillo, N D'Onofrio, ML Balestrieri Journal of Cardiovascular Pharmacology 69 (4), 183-191, 2017 | 76 | 2017 |
Peri-procedural tight glycemic control during early percutaneous coronary intervention up-regulates endothelial progenitor cell level and differentiation during acute ST … R Marfella, MR Rizzo, M Siniscalchi, P Paolisso, M Barbieri, C Sardu, ... International Journal of Cardiology 168 (4), 3954-3962, 2013 | 73 | 2013 |
MicroRNA‐33 and SIRT1 influence the coronary thrombus burden in hyperglycemic STEMI patients N D'Onofrio, C Sardu, P Paolisso, F Minicucci, F Gragnano, F Ferraraccio, ... Journal of Cellular Physiology 235 (2), 1438-1452, 2020 | 68 | 2020 |
Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment N D'Onofrio, C Sardu, MC Trotta, L Scisciola, F Turriziani, F Ferraraccio, ... Molecular Metabolism 54, 101337, 2021 | 67 | 2021 |
Stachydrine ameliorates high‐glucose induced endothelial cell senescence and SIRT 1 downregulation L Servillo, N D'Onofrio, L Longobardi, I Sirangelo, A Giovane, D Cautela, ... Journal of cellular biochemistry 114 (11), 2522-2530, 2013 | 62 | 2013 |